US Patent 7749532 Once daily formulations of tetracyclines
Patent 7749532 was granted and assigned to Supernus Pharmaceuticals, Inc. on July, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+338 characters)
Article
Patent abstract
Disclosed are once-daily formulations containing tetracyclines, especially doxycycline. Such formulations are useful, for instance, for the treatment of collagenase destructive enzyme-dependent diseases, such as periodontal disease and acne, and acute and chronic inflammatory disease states, such as rosacea and arthritis.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Arash Raoufinia0
Niraj Shah0
Rong-Kun Chang0
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07749532 Once daily formulations of tetracyclines US Patent 7749532 Once daily formulations of tetracyclines
Infobox
Patent Number
077495320
Patent Number
77495320
Edits on 4 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077495320
Date of Patent
July 6, 2010
0Patent Application Number
108196200
Date Filed
April 7, 2004
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07749532 Once daily formulations of tetracyclines
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07749532
Date of patent
July 6, 2010
Patent application number
10819620
Date Filed
April 7, 2004
Patent primary examiner
Find more entities like US Patent 7749532 Once daily formulations of tetracyclines
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
